Shanghai, China
Kerry Hotel Pudong, Shanghai, ChinaApril 28–29, 2026Dr. Tara Arvedson, PhDChief Scientific Officer at Hexagon BioSpeaker
Profile
Before joining Hexagon Bio, Dr. Arvedson held senior leadership roles at Amgen, including Executive Director of Oncology Research and Global Fastlane Network Lead, where she advanced bispecific T cell engager therapies, CAR T-cell programs, and the landmark KRAS G12C inhibitor Lumakras™, which earned the 2025 ACS Heroes of Chemistry Award.